Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Revenues
Operating Expenses        
Research and development (includes $201 and $0 of expense from stock compensation to officers, employees and directors vesting during the three months ended September 30, 2022 and 2021, and $327 and $0 for the nine months ended September 30, 2022 and 2021, respectively) 2,743 1,008 5,969 3,287
Selling, general and administrative (includes $2,743 and $577 of expense from stock compensation granted to officers, employees and directors during the three months ended September 30, 2022 and 2021, and $3,527 and $15,450 for the nine months ended September 30, 2022 and 2021, respectively) 4,280 4,946 9,510 36,050
Loss from Operations 7,023 5,954 15,479 39,337
Other (Income) Expense        
Interest income (107) (32) (151) (32)
Interest expense 696
Change in fair value of derivative liability (58) (502) (81) (43)
Unrealized loss on marketable securities 23 33 53 33
Total Other (Income) Expense (142) (501) (179) 654
Net Loss $ (6,881) $ (5,453) $ (15,300) $ (39,991)
Net loss per share – basic and diluted $ (0.22) $ (0.17) $ (0.48) $ (1.54)
Weighted average common shares outstanding – basic and diluted 31,380,634 31,381,282 31,723,792 25,945,827